(Q38209708)
Statements
1 reference
Systematic review of interleukin-12, interleukin-17, and interleukin-23 pathway inhibitors for the treatment of moderate-to-severe chronic plaque psoriasis: ustekinumab, briakinumab, tildrakizumab, guselkumab, secukinumab, ixekizumab, and brodalumab (English)
1 reference
William Tausend
1 reference
Christopher Downing
1 reference
Stephen Tyring
1 reference
1 May 2014
1 reference
1 reference
18
1 reference
3
1 reference
156-169
1 reference
Identifiers
1 reference